vitamin-d-2 and Thalassemia

vitamin-d-2 has been researched along with Thalassemia* in 2 studies

Other Studies

2 other study(ies) available for vitamin-d-2 and Thalassemia

Article	Year
Defective vitamin D metabolism in thalassemia major. Annals of the New York Academy of Sciences, 1985, Volume: 445 Topics: Adolescent; Adult; Calcitriol; Calcium; Chelating Agents; Child; Child, Preschool; Deferoxamine; Ergocalciferols; Female; Humans; Hydroxyproline; Iron; Liver; Male; Parathyroid Hormone; Phosphorus; Thalassemia; Vitamin D	1985
Combined vitamin D parathyroid defect in thalassemia major. Archives of internal medicine, 1982, Volume: 142, Issue:4 A 17-year-old girl with thalassemia major experienced tetany. The serum calcium level was 5.5 mg/dL, and the phosphorus level was 6.3 mg/dL. Serum levels of parathyroid hormone (PTH) and 25-hydroxyvitamin D (25-OHD) were subnormal at 125 pg/mL and 8.1 ng/mL, respectively, As a result of these findings, serum 25-OHD and PTH levels were measured in an additional 12 patients with thalassemia major. Low levels of both 25-OHD and PTH were found frequently. An increase in serum 25-OHD levels was noted in each of four patients who were examined after iron chelation therapy. Topics: 25-Hydroxyvitamin D 2; Adolescent; Adult; Child; Deferoxamine; Ergocalciferols; Female; Humans; Hypoparathyroidism; Male; Thalassemia	1982

Article

Year

Defective vitamin D metabolism in thalassemia major.

Annals of the New York Academy of Sciences, 1985, Volume: 445

Topics: Adolescent; Adult; Calcitriol; Calcium; Chelating Agents; Child; Child, Preschool; Deferoxamine; Ergocalciferols; Female; Humans; Hydroxyproline; Iron; Liver; Male; Parathyroid Hormone; Phosphorus; Thalassemia; Vitamin D

1985

Combined vitamin D parathyroid defect in thalassemia major.

Archives of internal medicine, 1982, Volume: 142, Issue:4

A 17-year-old girl with thalassemia major experienced tetany. The serum calcium level was 5.5 mg/dL, and the phosphorus level was 6.3 mg/dL. Serum levels of parathyroid hormone (PTH) and 25-hydroxyvitamin D (25-OHD) were subnormal at 125 pg/mL and 8.1 ng/mL, respectively, As a result of these findings, serum 25-OHD and PTH levels were measured in an additional 12 patients with thalassemia major. Low levels of both 25-OHD and PTH were found frequently. An increase in serum 25-OHD levels was noted in each of four patients who were examined after iron chelation therapy.

Topics: 25-Hydroxyvitamin D 2; Adolescent; Adult; Child; Deferoxamine; Ergocalciferols; Female; Humans; Hypoparathyroidism; Male; Thalassemia

1982